Clinical Trials Logo

Sleep Bruxism clinical trials

View clinical trials related to Sleep Bruxism.

Filter by:

NCT ID: NCT06343194 Recruiting - Sleep Bruxism Clinical Trials

Changes in Electromyographic Activity in Aligner Treatment of Adult Patients With and Without Nocturnal Bruxism

EMG_BRUX
Start date: February 9, 2023
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the effectiveness of clear aligners on the symptoms and signs reported by bruxism patients. The aim of the investigators is to evaluate the effect of treatment on the masticatory muscles and the changes related to the tropism of the masseter muscles using Bruxoff ® device, before and after the beginning of the therapy. Bruxoff ® is a holter that assesses the contractions of the masseter muscles and the heart during sleep. The plan is to compare treatment with clear aligners for bruxism and non-bruxism patients. The results will allow the investigators to evaluate the progress of clear aligner therapy in bruxism patients and compare them with those of non-bruxism patients.

NCT ID: NCT06259786 Completed - Nocturnal Bruxism Clinical Trials

Investigation of Adolescents With Nocturnal Bruxism

Start date: February 1, 2024
Phase:
Study type: Observational

The aim of this study is to examine the effects of bruxism on mandibular movement capacity, cervical proprioception, posture and quality of life in adolescents diagnosed with nocturnal bruxism (clenching and grinding teeth while sleeping) between the ages of 13-18 and to compare them with healthy adolescents. Method: A total of 40 adolescents, 20 with nocturnal bruxism and 20 healthy, will be included in the study. Mandibular movement capacity will be evaluated with a caliper and ruler, cervical proprioception with a CROM device, posture with the New York Posture Scale, and quality of life with the PedsQL 13-18 age scale. Hypotheses: H1: Nocturnal bruxism reduces the movement capacity of the mandible in adolescents. H2: Nocturnal bruxism reduces cervical proprioception in adolescents. H3: Posture disorder increases in adolescents with nocturnal bruxism. H4: Nocturnal bruxism affects the level of daily life quality in adolescents.

NCT ID: NCT06232993 Completed - Bruxism Clinical Trials

Management of Myofascial Pain in Children With Sleep Bruxism

Start date: December 1, 2022
Phase: N/A
Study type: Interventional

This study compared the effectiveness of Kinesio tape and occlusal splint application in improving sleep quality and reducing myofascial pain in children with sleep bruxism.

NCT ID: NCT06214637 Recruiting - Children Clinical Trials

Effectiveness of Melissa Officinalis for the Treatment of Probable Sleep Bruxism in Children and Adolescents

Start date: August 1, 2023
Phase: Phase 1
Study type: Interventional
Read more »
NCT ID: NCT06153810 Recruiting - Sleep Bruxism Clinical Trials

Efficacy of AesyBite Active in Reducing Sleep Bruxism Activity

Start date: November 17, 2023
Phase: N/A
Study type: Interventional

The overall objective of the clinical investigation is to evaluate whether the use of the AesyBite Active reduces the bruxism activity.

NCT ID: NCT05784454 Not yet recruiting - Sleep Bruxism Clinical Trials

Prevalance of Sleep Bruxism Among a Group of Egyptian Children

Start date: May 2, 2023
Phase:
Study type: Observational

The goal of this observational study is to detect the prevalence of sleep bruxism in a group of Egyptian children and detect its relation to screen-time and sugar consumption. The main questions it aims to answer are: 1. In a group of Egyptian Children what is the prevalence of sleep bruxism? 2. What is the relation between sleep bruxism and screen time and sugar consumption?

NCT ID: NCT05620316 Completed - Nocturnal Bruxism Clinical Trials

The Use of Low-Dose Botulinum Toxin Injection Into the Masseter Muscle to Treat Sleep Bruxism

Start date: March 15, 2021
Phase: N/A
Study type: Interventional

Botulinum toxin (BOTOX®) injections into the masseter muscle are an effective treatment for nocturnal bruxism, with several trials using various dosages of botulinum toxin for this purpose. The aim was to evaluate the effectiveness of injecting 10MU of botulinum toxin A (BTXA) into the masseter muscle to reduce nocturnal bruxism, the sample will randomly divided into 2 groups. In the injection group, Patients will inject with 10 MU of botulinum toxin type A (BOTOX® - Allergan Inc. - Dublin - Ireland) per side at two sites into the masseter muscle bilaterally. In this Placebo group, patients will prick twice at the inferior prominent part of the masseter muscle observed using the stinger pen used in the blood glucose meter. The evaluation will make by Electromyography (EMG) analysis, Visual Analogue Scale (VAS) values.

NCT ID: NCT05323942 Completed - Clinical trials for Sleep Bruxism, Childhood

The Effect of Sleep Hygiene and Exercise Therapy in Children With Sleep Bruxism

Start date: March 8, 2020
Phase: N/A
Study type: Interventional

The aims of this study were to determine the relationship between sleep bruxism, oral habits, and sleep habits and establish treatment approaches in children.

NCT ID: NCT05310162 Not yet recruiting - Clinical trials for Sleep Bruxism, Childhood

Effect of the Intervention "Food, Fun and Family" on Sleep Bruxism in Children

Start date: April 11, 2022
Phase: N/A
Study type: Interventional
Read more »
NCT ID: NCT05301452 Not yet recruiting - Sleep Bruxism Clinical Trials

Evaluation of Intravascular Irradiation of Blood in Children With Sleep Bruxism

Start date: October 1, 2022
Phase: Phase 2
Study type: Interventional
Read more »